Bookmark and Share

2010 archive

STUDY DEMONSTRATES SILIPHOS® HELPS CHEMOTHERAPY-ASSOCIATED LIVEL TOXICITY IN CHILDREN WITH LEUKEMIA 

 

2009 archive

POSITIVE PHARMACOLOGICAL AND CLINICAL DATA FOR CHEMOPREVENTION ON BILBERRY EXTRACT
Recent results from studies on Indena's standardized extracts in oncology 

SEMISYNTHESIS PACLITAXEL GRANTED CEP
The first company to receive this Certificate

AMERICAN BOTANICAL COUNCIL (ABC) NAMES INDENA RECIPIENT
OF VARRO E. TYLER AWARD DURING ANNUAL CEREMONY

 

2008 archive

PROF. APPENDINO AT THE HELM OF FITOTERAPIA JOURNAL
Indena's Director of Research and Development is the new Editor in Chief of the eminent journal for the study of medicinal plants 

INDENA PARTNERS WITH GUMBASE CO. IN DELIVERING THE SCIENCE OF NATURE THROUGH A NEXT GENERATION CHEWING GUM TECHNOLOGY

INDENA OBTAINS ECOCERT VALIDATION 
FOR OPEXTANTM AND ZANTHALENE®

NEW STUDY: MIRTOGENOLTM LOWERS HIGH INTRAOCULAR HYPERTENSIONS
Research shows First of its Kind Food Supplement Reduces Likelihood of Developing Glaucoma

INDENA JOINS COSMETIC VALLEY COMPETITIVITY POLE

INDENA RECEIVES THE FROST & SULLIVAN AWARD 2008 EUROPEAN GREEN TEA EXTRACTS EXCELLENCE IN RESEARCH

MIRTOSELECT® HELPS IN KIDNEY PROTECTION
Chinese researchers study its effects on a well-known nephrotoxic environmental pollutant



2007 archive

INDENA COMMUNICATION IS ACCLAIMED BY
THE ITALIAN SOCIETY OF CHEMISTRY AND COSMETOLOGY

BILBERRY EXTRACTS - SEE THE DIFFERENCES
A new study highlights the need to set common high quality standards

SPECTRUM PHARMACEUTICALS ACQUIRES FROM INDENA WORLDWIDE RIGHTS TO ORTATAXEL, A PHASE 2 THIRD GENERATION TAXANE

A GREEN LIGHT TO START PRODUCTION OF SEMISYNTHETIC PACLITAXEL
A brand new facility for the manufacture of high power cytotoxic active principles

 

2006 archive

PLANTS CAN HELP PREVENT CANCER
The Indena approach to chemoprevention presented at the 48O Annual Meeting of the Italian Cancer Society

MIRTOSELECT® NEW LOGO CAMPAIGN
Another mark of quality introduced by Indena

INDENA AND NERVIANO MEDICAL SCIENCES AGREE TO SCALE UP NEW HIGH POTENCY MOLECULES
Two leading Italian research centers join forces to develop new chemicals

PLANTS HELP FIGHT CARDIOVASCULAR DISORDERS
Indena approach to dietary antioxidant treatment con contribute to optimise nutrition

INDENA CONFIRMS WORLD LEADERSHIP IN BOTANICAL DERIVATIVES
Flourishing turnover and healthy profits highlighted in annual report

INDENA SIGNS LONG-TERM AGREEMENT WITH ALLIANCE PRINCIPLE INGREDIENTS AS  ITS CANADIAN DISTIBUTOR

EAST MEETS WEST TO UNVEIL SECRETS FOR A BEAUTIFUL SKIN 
Indena and Kanebo Cosmetics present their olive fruit extract OPEXTAN™

COSMETICS: INDENA TO FOCUS ON PRODUCING HIGH PURIFIED ACTIVE PRINCIPLE AND DRY EXTRACTS.
Fluid Extract lines to move to Greentech

 

2005 archive

THE SAFE CONSUMPTION OF SOY ISOFLAVONES AS HORMONE REPLACEMENT THERAPY
Fresh Evidence presented at the Chicago Symposium

Colon cancer: new possibilities of treatment from Colchicine derivatives
Indena illustrates its findings at the Stony Brook Symposium

Bilberry extracts: no more half truths
A new validated HPLC method by the Italian company Indena

MADEGLUCYL™, the natural way to maintain healthy blood sugar levels
Indena presents its new patented botanical derivative


BEAUTY FROM BOTANICAL ACTIVES
New cosmentic ingredients from the Italian company Indena


QUALITY IN NUTRITIONAL SUPPLEMENTS
Indena illustrates guidelines for biologically complex materials



Download 2004 archive

OLIVE FRUITS AS A SOURCE OF HEALTH
Indena innovative extract out of the Mediterranean tradition

Indena presents two studies on IDN 5390 at the 16th EORTC-NCI-AACR
PACLITAXEL RESISTANCE: AN ITALIAN WAY FORWARD


INDENA OPENS DEVELOPING PERSPECTIVES ON TAXANE DERIVATIVES RESEARCH

PRESIDENT OF THE INDENA SCIENTIFIC BOARD RECEIVES THE VARRO TYLER AWARD
Dr. Ezio Bombardelli awarded for research in botanicals during the
American Society of Pharmacognosy 2004 International Congress

THE ITALIAN COMPANY INDENA PRESENTS A NEW LINE ON CANCER RESEARCH
Four Indena studies presented during the 95th American Association of Cancer Research Congress (AACR)

INDENA MAKES PHYTOTHERAPY EVEN SAFER FOR BOTH PATIENTS AND THE ENVIRONMENT
New WHO guidelines on the cultivation of medicinal plants



Download 2003 archive

RISK OF HEART DISEASE REDUCED IN SMOKERS BY GRAPE SEEDS
An Italian study on Indena's LeucoselectTM Phytosome® extract was published in the recent October edition of the journal Metabolism

ITALIAN RESEARCH CONFIRMS THAT A NEW BOTANICAL ANTITUMOR MOLECULE IS READY FOR TOXICOLOGICAL AND CLINICAL DEVELOPMENT
During the international symposium on "Novel Approaches for the Discovery of Anticancer Agents" in Freiburg, the Milan National Tumor Institute presents its studies on Indena's IDN5390 molecule



Download 2002 archive

INDENA INTRODUCES POLINACEA
A NEW HIGHLY EFFECTIVE INGREDIENT FROM ECHINACEA

A NEW MOLECULE OBTAINED FROM PLANTS CAN MAKE
CHEMOTHERAPY MORE TOLERABLE AND EFFECTIVE

Three Italian studies presented in Frankfurt by Indena

REDUCTION OF MENOPAUSAL SYMPTOMS WITHOUT USE OF OESTROGENS: THE EFFICIENCY OF A PARTICULAR SOY EXTRACT IS SCIENTIFICALLY DEMONSTRATED

Understanding the Implications of the EU Traditional Herbal Medicine Directive: Indena shows the way in London
Indena sets out the importance for Higher Quality of Botanical Raw Materials

INDENA U.S.A. FREE OF PATENT INFRINGEMENT SUIT
United States Appeals Court dismisses
International Nutrition Company's patent infringement suit against Indena U.S.A.

INDENA'S SABALSELECT® CHOSEN FOR NIH SPONSORED CLINICAL TRIALS
The high quality of Indena's herbal products supported by their employment in American clinical trials



Download 2001 archive

INDENA SPONSORS ITALIAN RESEARCHERS' PARTICIPATION IN THE 2nd ITALIAN-JAPANESE SYMPOSIUM OF ORGANIC CHEMISTRY

TOWARDS MORE TOLERABLE CHEMOTHERAPY, WITH A NEW TAXANE MOLECULE

INDENA INCREASES ITS INTERNATIONAL PRESENCE
The Italian Company offers a world-wide market experience and research capabilities in the field of the botanical pure products

FDA APPROVES PHASE I CLINICAL TRIALS FOR POTENTIAL NEW ANTI-CANCER COMPOUND LICENSED TO BAYER BY INDENA

INDENA INAUGURATES ITS JAPANESE BRANCH
The Italian company consolidates its presence in the fifth largest global market




Indenature 2000

Indenature 2001

Indenature 2002

Indenature 2003

Indenature 2004

Indenature 2005

Indenature 2006

Indenature 2007

Indenature 2008

Indenature 2009

 
   

Company profile

Presentation

Research


Indena R&D

Products

Contacts

News

Events

Sponsorship
Membership


Fitoterapia
Journal


Indenature
newsletter


Brochures

Archive

Search for: any words all words

     
       
         

   
   
Get Adobe Reader
Contact us | Privacy Notice
Copyright © 2009 Indena S.p.A. All rights reserved
Indena S.p.A .tel.+39.02.574961 fax+39.02.57404620